Cizzle Brands Corporation Releases its Fiscal Q1 2026 Results

Cizzle Brands Corporation Releases its Fiscal Q1 2026 Results

Cizzle Brands Corporation (Cboe Canada: CZZL; OTCQB: CZZLF; Frankfurt: 8YF) ("Cizzle Brands" or the "Company"), a sports nutrition company that is elevating the game in health and wellness, today announced its financial results for the three months ended October 31, 2025.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251215668281/en/

Cizzle Brands Corporation released its Q1 2026 financial results, showing revenue growth of 18% YoY driven by strong on-shelf velocity of CWENCH Hydration.

Cizzle Brands Corporation released its Q1 2026 financial results, showing revenue growth of 18% YoY driven by strong on-shelf velocity of CWENCH Hydration.

Q1 FISCAL 2026 HIGHLIGHTS

  • Revenue increased 18% year-over-year to $3.3 million, compared to $2.8 million in Q1 Fiscal 2025
  • Gross profit of $1.8 million, representing a 54% gross margin
  • Expanded distribution across major retail banners including Loblaws, Real Canadian Superstore, Circle K, Petro-Canada and Pure Hockey
  • Successful launch of HappiEats Sport Pasta, expanding the Company's product portfolio beyond beverages and supplements
  • Secured a $5.0 million non-dilutive revolving credit facility to support working capital and growth
  • Strengthened Board of Directors with the addition of Ndamukong Suh, Geoff Bedford and Michael Doolan

MANAGEMENT COMMENTARY

"We are starting fiscal 2026 with strong momentum," said John Celenza, CEO of Cizzle Brands. "Revenue growth of 18% year-over-year reflects strong demand for CWENCH Hydration driven by strong on-shelf velocity. While we continue to invest in marketing, infrastructure and people, these investments are deliberate and aligned with our strategy to build category-leading brands. With our expanded retail presence, a strengthened Board, and access to non-dilutive capital, we believe Cizzle is extremely well positioned to execute on our growth plans and drive long-term shareholder value."

OUTLOOK

Cizzle Brands remains focused on expanding its presence across key retail, convenience, grocery and specialty channels in North America, while continuing to invest in brand-building, athlete partnerships and product innovation. Management expects these investments to support sustained revenue growth and margin improvement over time as scale efficiencies are realized.

FINANCIAL STATEMENTS AND MD&A

Cizzle's condensed consolidated interim financial statements and Management's Discussion and Analysis for the three months ended October 31, 2025 are available on SEDAR+ at www.sedarplus.com and on the Company's website at www.cizzlebrands.com .

About Cizzle Brands Corporation

Cizzle Brands Corporation is a sports nutrition company that is elevating the game in health and wellness. Through extensive collaboration and testing with leading athletes and trainers across several sports, Cizzle Brands has launched three game-changing brands: (i) CWENCH Hydration™, a better-for-you sports drink that is now carried in over 5,400 locations in Canada, the United States, and Europe; (ii) Spoken™ Nutrition, a premium brand of athlete-grade nutraceuticals that carry the prestigious NSF Certified for Sport® qualification; and (iii) HappiEats™, upgrading everyday eats with high-performance foods such as Sport Pasta™. All Cizzle Brands products are designed to help people of all ages achieve their best in competitive sports and in living a healthy, vibrant, active lifestyle.

For more information about Cizzle Brands, please visit: https://www.cizzlebrands.com/

For more information about CWENCH Hydration™, please visit: https://www.cwenchhydration.com

For more information about Spoken™ Nutrition, please visit: https://www.spokennutrition.com

For more information about HappiEats™, please visit https://www.myhappieats.com

On behalf of the Board of Directors of the Company,

Cizzle Brands Corporation

"John Celenza"

John Celenza, Founder, Chairman, and Chief Executive Officer

CAUTIONARY NOTE REGARDING FORWARD-LOOKING INFORMATION

This news release contains "forward-looking information" which may include, but is not limited to, information with respect to the activities, events or developments that the Company expects or anticipates will or may occur in the future, such as, but not limited to: expected financial results, new products of the Company and potential sales and distribution opportunities. Such forward-looking information is often, but not always, identified by the use of words and phrases such as "plans", "expects", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates", or "believes" or variations (including negative variations) of such words and phrases, or state that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved. Various assumptions or factors are typically applied in drawing conclusions or making the forecasts or projections set out in forward-looking information. Those assumptions and factors are based on information currently available to the Company.

Forward looking information involves known and unknown risks, uncertainties and other risk factors which may cause the actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking information. Such risks include risks related to increased competition and current global financial conditions, access and supply risks, reliance on key personnel, operational risks, regulatory risks, financing, capitalization and liquidity risks. Although the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking information. The Company undertakes no obligation, except as otherwise required by law, to update these forward-looking statements if management's beliefs, estimates or opinions, or other factors change.

Setti Coscarella
Head of Corporate Development
investors@cizzlebrands.com
1-844-588-2088

News Provided by Business Wire via QuoteMedia

CZZL:AQL
The Conversation (0)
Cizzle Brands Corporation (CBOE:CZZL)

Cizzle Brands Corporation

A Sports Nutrition Company Leading the Next Wave in Health and Wellness

A Sports Nutrition Company Leading the Next Wave in Health and Wellness Keep Reading...
Seegnal Inc. Receives Gold Mark from the Standards Institution of Israel, Advancing Commercialization Readiness

Seegnal Inc. Receives Gold Mark from the Standards Institution of Israel, Advancing Commercialization Readiness

Triple ISO Certification Recognition Positions Company as a Standard-Bearer in Clinical Decision Support Quality Infrastructure

Seegnal Inc. (TSXV: SEGN) ("Seegnal" or the "Company"), a global leader in clinical decision support solutions applying patient-centric medication safety standards, today announced that Seegnal eHealth Ltd., its Israeli operating subsidiary, has been granted the prestigious Gold Mark by the... Keep Reading...
Lexaria Bioscience Corp. (Nasdaq: LEXX)

Lexaria's New Animal Study Aims to Expand Valuable Intellectual Property

Lexaria Bioscience Corp. (Nasdaq: LEXX), (the “Company” or “Lexaria”), a global innovator in drug delivery platforms, is pleased to announce the engagement of the contract research organization (“CRO”) to execute and report on its 2026 animal Study #1 (GLP-1-A26-1) that will evaluate a number of... Keep Reading...
Lexaria's New Animal Study Aims to Expand Valuable Intellectual Property

Lexaria's New Animal Study Aims to Expand Valuable Intellectual Property

Contracts signed for Animal Study GLP-1-A26-1 KELOWNA, BC / ACCESS Newswire / April 15, 2026 / Lexaria Bioscience Corp. (NASDAQ:LEXX), (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, is pleased to announce the engagement of the contract research organization ("CRO")... Keep Reading...
Microscope and syringe overlay a digital stock chart with green lines and numbers.

Kailera, Alamar Target Billion-Dollar Valuations in Biotech Revival

Biotechnology initial public offerings (IPOs) are regaining momentum as easing market headwinds and an appetite for weight-loss drugs coax companies back to the public markets.On Monday (April 13) Reuters reported, that obesity drug developer Kailera Therapeutics and proteomics firm Alamar... Keep Reading...
Transparent blue cells with dark centers floating against a vibrant blue background.

Biotech and Pharma Market Update: Q1 2026 in Review

After a strong performance toward the end of 2025, the life science sector began the new year on a constructive note. Looking forward, signals in Q1 point to a market continuing to reward proof over promise. In an interview with the Investing News Network (INN), Eric Shrayer, partner and... Keep Reading...
A glass flask on a reflective table with overlaid stock market charts and numerical data, including text reading: 0.00%.

Anthropic Inks US$400 Million Deal for AI Biotech Startup Coefficient Bio

AI developer Anthropic is acquiring New York-based biotech startup Coefficient Bio for approximately US$400 million, according to The Information.Founded just last fall and operating largely in stealth, Coefficient Bio will be absorbed directly into Anthropic’s healthcare life sciences... Keep Reading...

Interactive Chart

Latest Press Releases

Related News